Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 15/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 15/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 15/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 13/20 | 0.41 |
| ▸ | CLK4 | Q9HAZ1 | 9/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 6/20 | 0.41 |
| ▸ | TSHR | P16473 | 11/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 8/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.40 |
| ▸ | USP2 | O75604 | 6/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.40 |
| ▸ | CASP7 | P55210 | 2/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | PDE9A | O76083 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29998774 | 1.00 | TP53 (0.41) | TP53GAACYP1A2CYP3A4CYP2C19 | |
| SCHEMBL29998362 | 0.87 | EGFR (0.41) | TP53GAACYP1A2CYP3A4CYP2C19 | |
| SCHEMBL24096504 | 0.87 | EGFR (0.41) | TP53GAACYP1A2CYP3A4CYP2C19 | |
| SCHEMBL24651143 | 0.83 | CYP1A2 (0.46) | TP53GAACYP1A2CYP3A4CYP2C19 | |
| SCHEMBL24651144 | 0.82 | NPC1 (0.43) | TP53GAACYP1A2CYP3A4CYP2C19 | |
| SCHEMBL30499571 | 0.81 | EGFR (0.40) | CYP1A2CYP3A4CYP2C19CYP2D6CLK4 | |
| SCHEMBL27217791 | 0.81 | NPC1 (0.42) | TP53GAACYP1A2CYP3A4CYP2C19 | |
| SCHEMBL20645215 | 0.78 | PDE9A (0.48) | CYP1A2CYP3A4CYP2C19CYP2D6CLK4 | |
| SCHEMBL29844225 | 0.78 | EGFR (0.43) | TP53CYP1A2CYP3A4CYP2C19CYP2D6 | |
| SCHEMBL23217165 | 0.78 | EGFR (0.43) | TP53CYP1A2CYP3A4CYP2C19CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117597346-A | NEK7 inhibitors | 哈利亚治疗公司 | 2024-02-23 | — | — | CN | disclosed |
| US-20230203045-A1 | INHIBITORS OF NEK7 KINASE | Halia Therapeutics, Inc. | 2023-06-29 | — | — | US | disclosed |
| US-20230203045-A1 | INHIBITORS OF NEK7 KINASE | Halia Therapeutics, Inc. | 2023-06-29 | — | — | US | disclosed |
| CN-116075513-A | Inhibitors of NEK7 kinase | 哈利亚治疗公司 | 2023-05-05 | — | — | CN | disclosed |
| WO-2021252488-A1 | INHIBITORS OF NEK7 KINASE | Halia Therapeutics, Inc. (US) | 2021-12-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203045-A1 | INHIBITORS OF NEK7 KINASE | NEK7, NEK1, NEK5 | TP53 1307/4885GAA 4273/4885CYP1A2 3396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.